Global Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 138
Published Date: 10 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Gastrointestinal Drugs market size was valued at USD 42110 million in 2023 and is forecast to a readjusted size of USD 56930 million by 2030 with a CAGR of 4.4% during review period.
Gastrointestinal (GI) disorder is a functional disorder or disease which occurs when the main abnormality is the way the body works. In the doctor’s office, no structural or biochemical cause is seen. Gastrointestinal problems occur when nerves or muscles in any portion of the digestive tract do not function in a coordinated fashion, or when the sensitivity of the nerves of the intestines or the way in which the brain controls some of these functions is impaired. In this report, we study the drugs for gastrointestinal.
The key players of Gastrointestinal Drugs include Takeda, AstraZeneca and Bayer, etc. The top three players hold a share over 9%. Asia-Pacific is the largest market, has a share about 25%. In terms of product type, Prescription is the largest segment, occupied for a share of about 64%, and in terms of application, Inflammatory Bowel Disease has a share about 44 percent.
The Global Info Research report includes an overview of the development of the Gastrointestinal Drugs industry chain, the market status of Inflammatory Bowel Disease (Prescription, OTC), IBS Disease (Prescription, OTC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Drugs.
Regionally, the report analyzes the Gastrointestinal Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Prescription, OTC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Drugs market.
Regional Analysis: The report involves examining the Gastrointestinal Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal Drugs:
Company Analysis: Report covers individual Gastrointestinal Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Inflammatory Bowel Disease, IBS Disease).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Drugs. It assesses the current state, advancements, and potential future developments in Gastrointestinal Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Prescription
OTC
Market segment by Application
Inflammatory Bowel Disease
IBS Disease
Peptic Ulcer
GERD
Other
Major players covered
Takeda
AstraZeneca
Bayer
Pfizer
Sun Pharma
Teva
Zeria
Perrigo
Eisai Co.
Abbvie
Jiangzhong
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Bausch Health
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal Drugs, with price, sales, revenue and global market share of Gastrointestinal Drugs from 2019 to 2024.
Chapter 3, the Gastrointestinal Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal Drugs.
Chapter 14 and 15, to describe Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gastrointestinal Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Prescription
1.3.3 OTC
1.4 Market Analysis by Application
1.4.1 Overview: Global Gastrointestinal Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Inflammatory Bowel Disease
1.4.3 IBS Disease
1.4.4 Peptic Ulcer
1.4.5 GERD
1.4.6 Other
1.5 Global Gastrointestinal Drugs Market Size & Forecast
1.5.1 Global Gastrointestinal Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Gastrointestinal Drugs Sales Quantity (2019-2030)
1.5.3 Global Gastrointestinal Drugs Average Price (2019-2030)
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Gastrointestinal Drugs Product and Services
2.1.4 Takeda Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Gastrointestinal Drugs Product and Services
2.2.4 AstraZeneca Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Gastrointestinal Drugs Product and Services
2.3.4 Bayer Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Gastrointestinal Drugs Product and Services
2.4.4 Pfizer Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sun Pharma
2.5.1 Sun Pharma Details
2.5.2 Sun Pharma Major Business
2.5.3 Sun Pharma Gastrointestinal Drugs Product and Services
2.5.4 Sun Pharma Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sun Pharma Recent Developments/Updates
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Gastrointestinal Drugs Product and Services
2.6.4 Teva Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Teva Recent Developments/Updates
2.7 Zeria
2.7.1 Zeria Details
2.7.2 Zeria Major Business
2.7.3 Zeria Gastrointestinal Drugs Product and Services
2.7.4 Zeria Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zeria Recent Developments/Updates
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business
2.8.3 Perrigo Gastrointestinal Drugs Product and Services
2.8.4 Perrigo Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Perrigo Recent Developments/Updates
2.9 Eisai Co.
2.9.1 Eisai Co. Details
2.9.2 Eisai Co. Major Business
2.9.3 Eisai Co. Gastrointestinal Drugs Product and Services
2.9.4 Eisai Co. Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eisai Co. Recent Developments/Updates
2.10 Abbvie
2.10.1 Abbvie Details
2.10.2 Abbvie Major Business
2.10.3 Abbvie Gastrointestinal Drugs Product and Services
2.10.4 Abbvie Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Abbvie Recent Developments/Updates
2.11 Jiangzhong
2.11.1 Jiangzhong Details
2.11.2 Jiangzhong Major Business
2.11.3 Jiangzhong Gastrointestinal Drugs Product and Services
2.11.4 Jiangzhong Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Jiangzhong Recent Developments/Updates
2.12 AOSAIKANG Pharma
2.12.1 AOSAIKANG Pharma Details
2.12.2 AOSAIKANG Pharma Major Business
2.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
2.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 AOSAIKANG Pharma Recent Developments/Updates
2.13 Luoxin Pharma
2.13.1 Luoxin Pharma Details
2.13.2 Luoxin Pharma Major Business
2.13.3 Luoxin Pharma Gastrointestinal Drugs Product and Services
2.13.4 Luoxin Pharma Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Luoxin Pharma Recent Developments/Updates
2.14 LIVZON
2.14.1 LIVZON Details
2.14.2 LIVZON Major Business
2.14.3 LIVZON Gastrointestinal Drugs Product and Services
2.14.4 LIVZON Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 LIVZON Recent Developments/Updates
2.15 Eastchina Pharma
2.15.1 Eastchina Pharma Details
2.15.2 Eastchina Pharma Major Business
2.15.3 Eastchina Pharma Gastrointestinal Drugs Product and Services
2.15.4 Eastchina Pharma Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Eastchina Pharma Recent Developments/Updates
2.16 Bausch Health
2.16.1 Bausch Health Details
2.16.2 Bausch Health Major Business
2.16.3 Bausch Health Gastrointestinal Drugs Product and Services
2.16.4 Bausch Health Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Bausch Health Recent Developments/Updates
3.1 Global Gastrointestinal Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Gastrointestinal Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Gastrointestinal Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2023
3.5 Gastrointestinal Drugs Market: Overall Company Footprint Analysis
3.5.1 Gastrointestinal Drugs Market: Region Footprint
3.5.2 Gastrointestinal Drugs Market: Company Product Type Footprint
3.5.3 Gastrointestinal Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Gastrointestinal Drugs Market Size by Region
4.1.1 Global Gastrointestinal Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Gastrointestinal Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Gastrointestinal Drugs Average Price by Region (2019-2030)
4.2 North America Gastrointestinal Drugs Consumption Value (2019-2030)
4.3 Europe Gastrointestinal Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Gastrointestinal Drugs Consumption Value (2019-2030)
4.5 South America Gastrointestinal Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Gastrointestinal Drugs Consumption Value (2019-2030)
5.1 Global Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
5.2 Global Gastrointestinal Drugs Consumption Value by Type (2019-2030)
5.3 Global Gastrointestinal Drugs Average Price by Type (2019-2030)
6.1 Global Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
6.2 Global Gastrointestinal Drugs Consumption Value by Application (2019-2030)
6.3 Global Gastrointestinal Drugs Average Price by Application (2019-2030)
7.1 North America Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
7.2 North America Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
7.3 North America Gastrointestinal Drugs Market Size by Country
7.3.1 North America Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Gastrointestinal Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Gastrointestinal Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Gastrointestinal Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Gastrointestinal Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
10.2 South America Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
10.3 South America Gastrointestinal Drugs Market Size by Country
10.3.1 South America Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Gastrointestinal Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Gastrointestinal Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Gastrointestinal Drugs Market Drivers
12.2 Gastrointestinal Drugs Market Restraints
12.3 Gastrointestinal Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Gastrointestinal Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gastrointestinal Drugs
13.3 Gastrointestinal Drugs Production Process
13.4 Gastrointestinal Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gastrointestinal Drugs Typical Distributors
14.3 Gastrointestinal Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Gastrointestinal Drugs Product and Services
Table 6. Takeda Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Gastrointestinal Drugs Product and Services
Table 11. AstraZeneca Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Gastrointestinal Drugs Product and Services
Table 16. Bayer Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bayer Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Gastrointestinal Drugs Product and Services
Table 21. Pfizer Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharma Major Business
Table 25. Sun Pharma Gastrointestinal Drugs Product and Services
Table 26. Sun Pharma Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sun Pharma Recent Developments/Updates
Table 28. Teva Basic Information, Manufacturing Base and Competitors
Table 29. Teva Major Business
Table 30. Teva Gastrointestinal Drugs Product and Services
Table 31. Teva Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Teva Recent Developments/Updates
Table 33. Zeria Basic Information, Manufacturing Base and Competitors
Table 34. Zeria Major Business
Table 35. Zeria Gastrointestinal Drugs Product and Services
Table 36. Zeria Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Zeria Recent Developments/Updates
Table 38. Perrigo Basic Information, Manufacturing Base and Competitors
Table 39. Perrigo Major Business
Table 40. Perrigo Gastrointestinal Drugs Product and Services
Table 41. Perrigo Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Perrigo Recent Developments/Updates
Table 43. Eisai Co. Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Co. Major Business
Table 45. Eisai Co. Gastrointestinal Drugs Product and Services
Table 46. Eisai Co. Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eisai Co. Recent Developments/Updates
Table 48. Abbvie Basic Information, Manufacturing Base and Competitors
Table 49. Abbvie Major Business
Table 50. Abbvie Gastrointestinal Drugs Product and Services
Table 51. Abbvie Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Abbvie Recent Developments/Updates
Table 53. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 54. Jiangzhong Major Business
Table 55. Jiangzhong Gastrointestinal Drugs Product and Services
Table 56. Jiangzhong Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Jiangzhong Recent Developments/Updates
Table 58. AOSAIKANG Pharma Basic Information, Manufacturing Base and Competitors
Table 59. AOSAIKANG Pharma Major Business
Table 60. AOSAIKANG Pharma Gastrointestinal Drugs Product and Services
Table 61. AOSAIKANG Pharma Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. AOSAIKANG Pharma Recent Developments/Updates
Table 63. Luoxin Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Luoxin Pharma Major Business
Table 65. Luoxin Pharma Gastrointestinal Drugs Product and Services
Table 66. Luoxin Pharma Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Luoxin Pharma Recent Developments/Updates
Table 68. LIVZON Basic Information, Manufacturing Base and Competitors
Table 69. LIVZON Major Business
Table 70. LIVZON Gastrointestinal Drugs Product and Services
Table 71. LIVZON Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. LIVZON Recent Developments/Updates
Table 73. Eastchina Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Eastchina Pharma Major Business
Table 75. Eastchina Pharma Gastrointestinal Drugs Product and Services
Table 76. Eastchina Pharma Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eastchina Pharma Recent Developments/Updates
Table 78. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 79. Bausch Health Major Business
Table 80. Bausch Health Gastrointestinal Drugs Product and Services
Table 81. Bausch Health Gastrointestinal Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Bausch Health Recent Developments/Updates
Table 83. Global Gastrointestinal Drugs Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 84. Global Gastrointestinal Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Gastrointestinal Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 86. Market Position of Manufacturers in Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
Table 88. Gastrointestinal Drugs Market: Company Product Type Footprint
Table 89. Gastrointestinal Drugs Market: Company Product Application Footprint
Table 90. Gastrointestinal Drugs New Market Entrants and Barriers to Market Entry
Table 91. Gastrointestinal Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (M Units)
Table 93. Global Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (M Units)
Table 94. Global Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Gastrointestinal Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 97. Global Gastrointestinal Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 98. Global Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 99. Global Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 100. Global Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Gastrointestinal Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 103. Global Gastrointestinal Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 104. Global Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 105. Global Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 106. Global Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Gastrointestinal Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 109. Global Gastrointestinal Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 110. North America Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 111. North America Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 112. North America Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 113. North America Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 114. North America Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 115. North America Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 116. North America Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 119. Europe Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 120. Europe Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 121. Europe Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 122. Europe Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 123. Europe Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 124. Europe Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 127. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 128. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 129. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 130. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (M Units)
Table 131. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (M Units)
Table 132. Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 135. South America Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 136. South America Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 137. South America Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 138. South America Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (M Units)
Table 139. South America Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (M Units)
Table 140. South America Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (M Units)
Table 143. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (M Units)
Table 144. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (M Units)
Table 145. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (M Units)
Table 146. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (M Units)
Table 147. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (M Units)
Table 148. Middle East & Africa Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Gastrointestinal Drugs Raw Material
Table 151. Key Manufacturers of Gastrointestinal Drugs Raw Materials
Table 152. Gastrointestinal Drugs Typical Distributors
Table 153. Gastrointestinal Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal Drugs Picture
Figure 2. Global Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal Drugs Consumption Value Market Share by Type in 2023
Figure 4. Prescription Examples
Figure 5. OTC Examples
Figure 6. Global Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Gastrointestinal Drugs Consumption Value Market Share by Application in 2023
Figure 8. Inflammatory Bowel Disease Examples
Figure 9. IBS Disease Examples
Figure 10. Peptic Ulcer Examples
Figure 11. GERD Examples
Figure 12. Other Examples
Figure 13. Global Gastrointestinal Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Gastrointestinal Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Gastrointestinal Drugs Sales Quantity (2019-2030) & (M Units)
Figure 16. Global Gastrointestinal Drugs Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Gastrointestinal Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Gastrointestinal Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Gastrointestinal Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Gastrointestinal Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Gastrointestinal Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 55. China Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Gastrointestinal Drugs Market Drivers
Figure 76. Gastrointestinal Drugs Market Restraints
Figure 77. Gastrointestinal Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Gastrointestinal Drugs in 2023
Figure 80. Manufacturing Process Analysis of Gastrointestinal Drugs
Figure 81. Gastrointestinal Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda AstraZeneca Bayer Pfizer Sun Pharma Teva Zeria Perrigo Eisai Co. Abbvie Jiangzhong AOSAIKANG Pharma Luoxin Pharma LIVZON Eastchina Pharma Bausch Health
Related Reports
25 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
